
Anjana Joel
@ajoel_84
Medical oncologist at CMC Vellore
ID: 333288767
11-07-2011 09:07:13
15 Tweet
185 Followers
534 Following


New research adds to the limited data on outcomes and optimal treatment for primary mediastinal germ cell tumours in the setting of low and middle income countries Anjana Joel CMC Vellore (Official) ecancer.org/en/journal/art…



Protocol group 3 meditating our way to a bronze medal in the #ACORD21 Gala quiz night ACORD Initiative Dr Deme Karikios Carol Chan Thanks for a great week!


Our work from CMC. Patients not clearing EGFR mutation in plasma at first followup have inferior PFS. Presented at KSMO2021 and chosen for Oral Presentation Award.Thanks to colleagues Raju Chacko,Rekha Pai, Ashish Singh, Josh Thomas Georgy, Ajoy Oommen John, Divya Thumaty #KSMO21 #LCSM #EGFR



Time to move away from Dexamethasone for prevention of chemotherapy induced nausea and vomiting (CINV). ✅ Phase 3 double blind RCT ✅ DEX free prophylaxis is effective ✅ Lesser side effects like insomnia ascopubs.org/doi/10.1200/GO… JCO Global Oncology

🌟 We are glad to share our study on the mutational landscape in TNBC pre vs. post neoadjuvant therapy. Led by Ashish Singh Sir and Dr Rekha Pai, Raju Chacko Anjana Joel Divya Thumaty Ajoy Oommen John Dr.Elanthenral Sigamani CMC Vellore (Official) #TNBC #bcsm #LMICresearch pubmed.ncbi.nlm.nih.gov/37951371/ 👇details



